European Drug Report: Trends and Developments 2019

The 2019 report from the European Monitoring Centre for Drugs and Drug Addiction has been released. This report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses.

The report covers the extent of naloxone provision as a response to overdose deaths:

Recent systematic reviews of the effectiveness of take home naloxone programmes have found evidence that its
provision in combination with educational and training interventions reduces overdose-related mortality.

In 2018, community-based take-home naloxone programmes were operating in 10 European countries. These programmes are commonly run by drugs and health services, with the exception of Italy, where naloxone is an over-the-counter medication. Prisoners are included as a target population in the take-home naloxone programmes in Estonia, France, the United Kingdom and Norway

Key approaches for reducing opioid-related deaths

Key approaches for reducing opioid-related deaths

Read report

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT